The oncology market for PROTACs is projected to reach $3.7 billion by 2030, even though there are no FDA approved therapies currently. Highlights: Protein homeostasis is critical for physiology of cell and their functioningPROTACs have the ability to target and degrade specific oncoproteins, facilitating prolonged efficacy and fewer side-effects in cancer treatmentVarious on-going clinical trials show promising results of PROTAC pipeline products✔ ✔ Trusted SourcePROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat CancerGo to source Trusted Source‘Approximately 33% of cancer-related deaths can be attributed to the utilization of tobacco, high body mass index, excessive alcohol consumption, inadequate consumption of fruits and vegetables. Insufficient physical activity too can be a cause of cancer! #cancer #medindia’Proteolytic Regulation in Cancer Research✔ ✔ Trusted SourcePROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat CancerGo to source Trusted SourcePROTACs As a Strategy for Cancer Treatment✔ ✔ Trusted SourcePROTAC: A promising technology for cancer treatmentGo to source Trusted SourceClinical Trials on PROTACsChallenges Associated with PROTACs and Efforts to OvercomeFuture of PROTACs as Long-term Anticancer Therapeutics✔ ✔ Trusted SourceAn overview of PROTACs: a promising drug discovery paradigmGo to source Trusted SourcePROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat Cancer - (https://aacrjournals.org/mct/article/23/4/454/741867/PROTACs-Current-and-Future-Potential-as-a) PROTAC: A promising technology for cancer treatment - (https://pubmed.ncbi.nlm.nih.gov/32698111/) An overview of PROTACs: a promising drug discovery paradigm - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763089/)